A recent MR study genetically determined that elevated plasma MPO levels are causally associated with increased risks of ischemic stroke, cardioembolic stroke (CES), heart failure (HF), and atrial fibrillation (AF) [18]. This evidence concerns the gene MPO and atrial fibrillation.